Can Evolus Disrupt the Botox Market?

The facial injections industry is estimated to be valued at $13.4 billion and is expected to grow at an 8.8% compound annual growth rate until 2028. The leader in facial injections is the well-known Botox product, which was invented by Allergan, a company now owned by biotechnology giant AbbVie (NYSE:ABBV). The product wins over $1 billion in sales a year just in cosmetics (non-medical injections). However, a product from performance beauty company Evolus (NASDAQ:EOLS) called Jeuveau is looking to shake up the facial injections market. Does Evolus have what it takes?